IRD vs AAPL: Which Stock is Better?
Side-by-side comparison of Opus Genetics Inc and Apple Inc in 2026
IRD
Opus Genetics Inc
$5.71
AAPL
Apple Inc
$266.65
Key Metrics Comparison
| Metric | IRD | AAPL | Winner |
|---|---|---|---|
| Market Cap | $396.30M | N/A | IRD |
| P/E Ratio | N/A | 32.80 | AAPL |
| EPS (TTM) | $N/A | $7.89 | AAPL |
| Revenue Growth | -0.1% | 0.2% | AAPL |
| Gross Margin | -117.0% | 47.3% | AAPL |
Analyze IRD
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRD or AAPL a better investment?
Comparing IRD and AAPL: Opus Genetics Inc has a market cap of $396.30M while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRD and AAPL?
IRD (Opus Genetics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRD or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRD or AAPL?
AAPL has higher revenue growth at 0.2% vs -0.1% for IRD.
Which company is more profitable: IRD or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -117.0% for IRD.
Which is the larger company: IRD or AAPL?
Opus Genetics Inc (IRD) is larger with a market cap of $396.30M compared to N/A for AAPL.
Should I buy IRD or AAPL in 2026?
Both IRD and AAPL have investment merit. IRD trades at $5.71 while AAPL trades at $266.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRD and AAPL stock?
Key differences: Market Cap ($396.30M vs N/A), P/E Ratio (N/A vs 32.8x), Revenue Growth (-0.1% vs 0.2%), Gross Margin (-117.0% vs 47.3%).